Cyfip1 is a putative invasion suppressor in epithelial cancers.
about
α5β1 integrin recycling promotes Arp2/3-independent cancer cell invasion via the formin FHOD3.WAVE2 regulates epithelial morphology and cadherin isoform switching through regulation of Twist and AblA novel role of protein tyrosine kinase2 in mediating chloride secretion in human airway epithelial cellsCyfip1 Regulates Presynaptic Activity during DevelopmentScreenBEAM: a novel meta-analysis algorithm for functional genomics screens via Bayesian hierarchical modelingThe transcriptome of the bowhead whale Balaena mysticetus reveals adaptations of the longest-lived mammalScar/WAVE3 contributes to motility and plasticity of lamellipodial dynamics but not invasion in three dimensions.Arpin downregulation in breast cancer is associated with poor prognosis.New insights into the regulatory function of CYFIP1 in the context of WAVE- and FMRP-containing complexes.Differential expression of CHL1 gene during development of major human cancers.Arp2/3 promotes junction formation and maintenance in the Caenorhabditis elegans intestine by regulating membrane association of apical proteins.Adhesion molecule periplakin is involved in cellular movement and attachment in pharyngeal squamous cancer cellsBridging HIV-1 cellular latency and clinical long-term non-progressor: an interactomic viewWAVE3, an actin remodeling protein, is regulated by the metastasis suppressor microRNA, miR-31, during the invasion-metastasis cascade.Loss of Wave1 gene defines a subtype of lethal prostate cancerCYFIP1 is directly controlled by NOTCH1 and down-regulated in cutaneous squamous cell carcinomaHDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancersDisruption of Abi1/Hssh3bp1 expression induces prostatic intraepithelial neoplasia in the conditional Abi1/Hssh3bp1 KO mice.Crk and ABI1: binary molecular switches that regulate abl tyrosine kinase and signaling to the cytoskeleton.Targeting the WASF3-CYFIP1 Complex Using Stapled Peptides Suppresses Cancer Cell Invasion.Lamellipodia are crucial for haptotactic sensing and response.The fragile X protein binds mRNAs involved in cancer progression and modulates metastasis formation.A genome-wide screen identifies conserved protein hubs required for cadherin-mediated cell-cell adhesion.CYFIP family proteins between autism and intellectual disability: links with Fragile X syndrome.Towards systematic functional characterization of cancer genomes.Endocytosis and signaling: cell logistics shape the eukaryotic cell plan.Abi1, a critical molecule coordinating actin cytoskeleton reorganization with PI-3 kinase and growth signaling.Expression profile of genes regulated by curcumin in Y79 retinoblastoma cells.WAVE/SCAR promotes endocytosis and early endosome morphology in polarized C. elegans epithelia.ABI3, a component of the WAVE2 complex, is potentially regulated by PI3K/AKT pathwayWAVE regulates Cadherin junction assembly and turnover during epithelial polarization.The Arp2/3 Regulatory System and Its Deregulation in Cancer.Cyfip1 is downregulated in acute lymphoblastic leukemia and may be a potential biomarker in acute lymphoblastic leukemia.Expression of Abl interactor 1 and its prognostic significance in breast cancer: a tissue-array-based investigation.Transcriptomics analysis reveals new insights in E171-induced molecular alterations in a mouse model of colon cancer.Actin-Based Cell Protrusion in a 3D Matrix
P2860
Q27310096-05000BAE-23F4-4310-9448-DE2C9BF5E955Q27318554-A575ABFB-58B5-484E-A45A-2EED8DBDCEB2Q28478998-705D21CA-0ABD-44CD-B17E-81BC4914422DQ28566588-0A50EDC1-AE0F-42B6-8B86-27F755EF6680Q28601274-2C0E8274-D31D-463C-89F6-88E32B612342Q28651042-EBD3BC11-A0D8-48F1-866D-86B24DAAF455Q30572341-877028CA-6FDB-452D-9756-64FE1848AF7CQ30724719-19A6E86A-9485-41E3-A08F-A0D1B00FF294Q33588069-F8D608A6-6C5B-4C85-816A-82851B1AF9C5Q33847826-625B5E50-E0BA-4BC8-B8DA-1E55CCC26246Q33940408-390B71D0-6826-4BA4-B242-6FFF2B3E21A7Q34032612-2B798A88-60E1-47F6-9E3C-53684681EEC2Q34602260-9137B23C-B6C2-4983-A791-099C0A0D686CQ34842373-9C1C63FF-9211-4968-A305-0DBF24EED230Q35828579-6E12AE61-2BE0-4F52-A828-7997ED089906Q36347136-DD96454E-A918-4ABC-AE4D-825ACB8F3FD6Q36354259-0A07F422-FE93-4020-AFD2-D9CBC2967A4CQ36415133-5C1C5DF6-6EAF-4136-9281-4D3D80C04DDAQ36443397-390F115C-BDFC-4FF5-9E70-DEA6CA626314Q36790763-F7E912CA-6A7D-441B-B614-D97F4B897E99Q37036429-B8B27536-A1B0-4AE2-AB0A-C1B707798138Q37237119-D568B5B1-92E8-4607-A3A7-7A903095D9F7Q37498579-8C66F4CA-53D3-43CE-BA16-8B4EC186B11BQ37681411-499C1BBC-1C2E-4C2B-B36E-00828368F2A6Q37890867-8B8AABBD-F66A-444B-85DA-057D64F9FB18Q37980726-F028B7CE-4879-4023-90FB-4368B80E083AQ38012229-6428F7A9-9FEF-4838-AADB-41E6B3DCAA46Q39366939-349757DE-70E1-42AF-8263-FC63AD9E62EAQ42090364-577AFDF0-4A86-4814-BF70-05139E0DC26FQ42366575-C4B09515-121E-44C5-84F2-44D28F7235ACQ47311762-70176FB7-6C15-4D46-9D43-4E3E90DBDF3DQ47322418-1A166B44-301C-4495-8224-0C4533079D19Q53205834-FECB2D41-025A-47DA-8887-18F558486EAEQ54635876-4647C77B-8BE1-464D-A50A-BB2ABB384AEEQ55430424-6A592978-C1E0-4B3B-8728-9396D4DC717DQ58794107-23B2166C-A9BA-490B-A5B2-FE6270EFA952
P2860
Cyfip1 is a putative invasion suppressor in epithelial cancers.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Cyfip1 is a putative invasion suppressor in epithelial cancers.
@ast
Cyfip1 is a putative invasion suppressor in epithelial cancers.
@en
type
label
Cyfip1 is a putative invasion suppressor in epithelial cancers.
@ast
Cyfip1 is a putative invasion suppressor in epithelial cancers.
@en
prefLabel
Cyfip1 is a putative invasion suppressor in epithelial cancers.
@ast
Cyfip1 is a putative invasion suppressor in epithelial cancers.
@en
P2093
P2860
P50
P1433
P1476
Cyfip1 is a putative invasion suppressor in epithelial cancers.
@en
P2093
Elena Ezhkova
Felix Bonilla
Javier Silva
Jose M Silva
Mireia Castillo
Scott Powers
Senthil K Muthuswamy
Stephen Heart
Veronica Castro
Yolanda Campos
P2860
P304
P356
10.1016/J.CELL.2009.04.013
P407
P577
2009-06-01T00:00:00Z